Your email has been successfully added to our mailing list.

×
0.0623749999999999 0.0625000000000001 0.15 0.0600000000000001 0.0562500000000001 0.00312499999999993 -0.0523750000000001 -0.04375
Stock impact report

Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK

Neovasc Inc. - Common Shares (NVCN) 
Last neovasc inc. - common shares earnings: 3/30 04:08 pm Check Earnings Report
US:NASDAQ Investor Relations: neovasc.com/neovasc-investment/overview
Company Research Source: PR Newswire
Successfully completed all Phase 1 requirements of TIARA-IINASDAQ, TSX: NVCN VANCOUVER, Jan 29, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that it has completed the Phase 1 requirements of the TIARA-II study required by the bi-phasic study design in both Germany and the United Kingdom and has received approval to proceed with Phase 2 of the TIARA-II study for its Tiara™ transcatheter mitral valve replacement device (the "Tiara").  This approval comes following Clinical Events Committee adjudication of adverse events, Data and Safety Monitoring Board review of the data, and Governmental regulatory and ethics committees reviews of the interim clinical report provided for 20 implanted subjects. This approval will allow the TIARA-II st Show less Read more
Impact Snapshot
Event Time:
NVCN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for NVCN alerts
Opt-in for
NVCN alerts

from News Quantified
Opt-in for
NVCN alerts

from News Quantified